And reporting negative or unexpected results is just as essential as sharing success stories — it’s how our field continues to evolve.

#PrimaryImmunodeficiency #Immunology #HSCT #RareDiseases

BUT another important point here is that this is not a story of triumph, but rather a humble reflection — a reminder that we, as clinicians and scientists, still have much to learn from our patients.

This work expands our understanding of the non-canonical NF-κB pathway in immune reconstitution and highlights the challenges of treating such rare IEIs.